Loading clinical trials...
Loading clinical trials...
This is an open-label, multicenter study of participants with late-onset Pompe disease naive to treatment with enzyme replacement therapy (ERT). The primary objective of this study is to evaluate glyc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genzyme, a Sanofi Company
NCT07282847 · Pompe Disease (Late-onset), Pompe Disease Late-Onset, and more
NCT06150820 · Pompe Disease (Late-onset)
NCT04174105 · Pompe Disease (Late-onset)
NCT03911505 · Pompe Disease (Late-onset)
NCT03694561 · Pompe Disease, Pompe Disease (Late-onset), and more
Orange, California
Gainesville, Florida
Kansas City, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions